Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
45%
OVERLAP
BY WEIGHT
58
# OF OVERLAPPING
HOLDINGS
RSPH
63
HOLDINGS
97%
ALSO IN IXJ
IXJ
114
HOLDINGS
56%
ALSO IN RSPH
SECTOR DRIFT (RSPH minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in RSPH |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 2.2% | 10.3% | 2.2% |
|
MERCK & CO. INC. | 2.1% | 4.2% | 2.1% |
|
JOHNSON & JOHNSON | 2.0% | 6.9% | 2.0% |
|
AMGEN INC | 1.9% | 2.8% | 1.9% |
|
UNITEDHEALTH GROUP INC | 1.8% | 4.1% | 1.8% |
RSPH Overweight Relative to IXJ
|
MODERNA, INC. | 3.8% |
|
CENTENE CORP | 2.6% |
|
DAVITA INC | 2.3% |
|
VIATRIS, INC. | 2.1% |
|
ALIGN TECHNOLOGY INC | 2.0% |
|
HOLOGIC INC | 1.8% |
|
BIOGEN IDEC INC | 1.7% |
|
HENRY SCHEIN INC | 1.7% |
|
PERKINELMER INC | 1.7% |
|
CHARLES RIVER LABORATORIES | 1.7% |
RSPH Underweight Relative to IXJ
|
ELI LILLY & CO | -8.0% |
|
JOHNSON & JOHNSON | -4.9% |
 |
NOVARTIS AG | -3.4% |
|
ABBVIE INC | -3.3% |
 |
ASTRAZENECA PLC | -3.0% |
|
UNITEDHEALTH GROUP INC | -2.3% |
|
MERCK & CO. INC. | -2.1% |
 |
NOVO NORDISK A/S-B | -1.8% |
|
ABBOTT LABORATORIES | -1.4% |
|
GSK PLC | -1.2% |